Androgenic Alopecia – Drugs In Development, 2024
Powered by ![]()
Unlock hidden opportunities in the Pharmaceuticals industry
Empower your strategies with our Androgenic Alopecia – Drugs In Development, 2024 report and make more profitable business decisions.
Androgenic alopecia, commonly known as male-pattern baldness or female-pattern hair loss, is a hereditary condition that leads to gradual hair thinning and eventual hair loss in a specific pattern. It is the most common type of hair loss and affects both men and women, although the presentation and progression may differ between the sexes. Androgenic alopecia is primarily influenced by genetic and hormonal factors. It is associated with the hormone dihydrotestosterone (DHT), a derivative of testosterone, which can affect hair follicles by causing them to shrink or miniaturize over time. This results in shorter and thinner hair growth cycles, leading to eventual hair loss. The primary symptom of androgenic alopecia is a gradual reduction in hair volume and thickness in the affected areas. Hair may become finer, shorter, and less dense, ultimately leading to visible scalp exposure.
The Androgenic Alopecia drugs in development market research report provide comprehensive information on the therapeutics under development for Androgenic Alopecia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action and product description of the therapeutics, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Androgenic Alopecia and features dormant and discontinued products.
Note:
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.
* Certain sections in the report may be removed or altered based on the availability and relevance of data.
| Quick View – Androgenic Alopecia | Key Targets |
|
|
| Key Mechanisms of Action |
|
||
| Key Routes of Administration |
|
||
| Key Molecule Types |
|
||
| Major Companies |
|
||
Scope
- Therapeutics in Development: Covering 43 molecules, with 43 developed by companies and the rest by universities/institutes.
- Analysis Parameters: Offering insights by stage of development, drug target, MoA, RoA, and molecule type for a comprehensive overview.
- Pharmacological Insights: Understand the descriptive pharmacological action of therapeutics.
- Development History: Access the complete research and development history.
- Latest News and Press Releases: Stay updated with the latest developments through comprehensive news coverage.
Reasons to Buy
- Holistic insights: Understand the broad spectrum of Androgenic Alopecia therapeutics, aiding strategic decision-making with insights into stages, targets, MoA, RoA and molecule types.
- Pipeline Exploration: Explore the detailed Androgenic Alopecia pipeline, offering nuanced analysis of drug targets, mechanisms of action and routes of administration for varied decision-making.
- Comprehensive R&D: Access thorough R&D histories, providing a comprehensive understanding of Androgenic Alopecia treatments for adaptable decision-making.
- Save valuable hours: Identify key players steering innovation in therapeutics, enabling strategic partnerships.
Key Players
Addpharma IncAlmirall SA
Amplifica Holdings Group Inc
Aneira Pharma Inc
Anhorn Medicines Co Ltd
Chong Kun Dang Pharmaceutical Corp.
Cosmo Pharmaceuticals NV
Cutia Therapeutics (HK) Ltd
Dermaliq Therapeutics Inc
dNovo Inc
Eirion Therapeutics Inc
EMS SA
Epibiotech Co Ltd
Exicure Inc
Follica Inc
Follicle Pharma Ltd
Gurus BioPharm Inc
Hangzhou Metai Pharmaceutical Technology Co Ltd
Hope Medicine Inc
Innovo Therapeutics Co Ltd
Inventage Lab Inc
Kanpecia Biotech LLC
Kintor Pharmaceutical Ltd
Mallia Therapeutics GmbH
Merz Pharma GmbH & Co KgaA
Nanjing Minova Pharmaceutical Technology Co Ltd
OliX Pharmaceuticals Inc
Pelage Pharmaceuticals Inc
RiverTown Therapeutics Inc
Safety Shot Inc
Samson Clinical Pty Ltd
Ship of Theseus LLC
Sichuan Huiyu Pharmaceutical Co Ltd
Technoderma Medicines Inc
Triple Hair Inc
VeraDermics Inc
Table of Contents
Table
Figures
Frequently asked questions
Related reports
View more Androgenic Alopecia reports